The cryoglobulinemic syndrome - Report from the workshop on classification and on the 10th conference of the Italian Society for the treatment of Cryoglobulinemia, Modena, 29. Sept. 2003;Das kryoglobulinämische syndrom: Bericht vom workshop zur klassifikation und der 10. Tagung der Italienischen Gesellschaft zur behandlung der Kryoglobulinämie, Modena, 29. 9. 2003

Zeitschrift fur Rheumatologie

Volumn 63, Issue 3, 2004, Pages 235-238

  Lamprecht, P ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Autoantibody B cell; Cryoglobulinemic syndrome; Hepatitis C virus

Indexed keywords

AUTOANTIGEN; PROTEIN BCL 2; PROTEIN P53; VIRUS PROTEIN;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL STIMULATION; CELL SURVIVAL; CONFERENCE PAPER; CROSS REACTION; CRYOGLOBULINEMIA; CRYOGLOBULINEMIA SYNDROME; CYTOMEGALOVIRUS; DISEASE CLASSIFICATION; HEPATITIS C VIRUS; HUMAN; IMMUNITY; PATHOGENESIS; PROTO ONCOGENE; SYSTEMIC SCLEROSIS; CLASSIFICATION; EDUCATION; ITALY; MEDICAL SOCIETY; SYNDROME;

CRYOGLOBULINEMIA; EDUCATION; HUMANS; ITALY; SOCIETIES, MEDICAL; SYNDROME;

EID: 3042716502     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Bason C et al (2003) In atherosclerosis antibodies against HSP60 bind human cytomegalovirus-derived proteins and induce apoptosis of non-stressed endothelial cells. Lancet (in press)
2. Ferri C, Zignego AL, Pileri SA (2002) Cryoglobulins. J Clin Pathol 55:4-13
3. Invernizzi F, Galli M, Serino G, Monti G, Meroni PL, Granatieri C, Zanussi C (1983) Secondary and essential cryoglobulineamias: Frequency, nosological classification and long-term follow-up. Acta Haemat 70:73-82
4. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico A, Rees AJ, van Es LA, Waldherr R, Wiik A (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187-192
5. Lamprecht P, Lerin-Lozano C, Merz H, Dennin RH, Cause A, Voswinkel J, Peters SO, Gutzeit O, Arlt AC, Solbach W, Gross WL (2003) Rituximab induces remission in refractory HCV-associated cryoglobulinemic vasculitis. Ann Rheum Dis 62:1230-1233
6. Lunardi C, Bason C, Navone R, Millo E, Damonte G, Corrocher R, Puccetti A (2000) Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endithelial cells. Nat Med 6:1183-1186
7. Monti G, Galli M, Invernizzi F, Piotellli P, Saccardo F, Monteverde A, Pietrogrande M, Renoldi P, Bombardieri S, Bordoni G, Candela M, Ferri C, Gabrielli A, Mazzaro C, Migliaresi S, Mussini C, Ossi E, Quintiliani L, Tirri G, Vacca A (1995) Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. Q J Med 88:115-126
8. Sansonno D, De Re V, Lauletta G, Tucci FA, Boiocchi M, Dammacco F (2003) Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood 101:3818-3826
9. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, Bjerrum KB, Braga S, Coll J, de Vita S et al (1993) Preliminary criteria for the classification of Sjögren's sysndrome. Results of a prospective concerted action supported by the European community. Arthritis Rheum 36:340-347
10. Zaja F, De Vita S, Mazzaro C, Sacco S, Damiani D, De Marchi G, Michelutti A, Baccarani M, Fanin R, Ferraccioli G (2003) Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 101:3827-3834